Shire PLC (SHPGY) financial statements (2021 and earlier)

Company profile

Business Address BLOCK 2, MIESIAN PLAZA
DUBLIN 2, D02 HW68
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments193260318472209264369
Cash and cash equivalents193260318472209264369
Restricted cash and investments40353639343434
Receivables3,2073,0053,1413,0702,8412,7552,580
Inventory, net of allowances, customer advances and progress billings3,4593,3533,3413,2923,4273,3253,346
Inventory3,4593,3533,3413,2923,4273,3253,346
Prepaid expense   243   
Other current assets900  313   
Other undisclosed current assets 3,1351,081180780779787
Total current assets:7,7999,7887,9157,6087,2927,1577,116
Noncurrent Assets
Property, plant and equipment6,4536,4276,4606,6356,5806,5556,496
Long-term investments and receivables471528272241200197226
Long-term investments471528272241200197226
Intangible assets, net (including goodwill)48,72049,15452,85352,87853,06952,91651,983
Goodwill19,09519,04419,98919,83219,71819,48219,149
Intangible assets, net (excluding goodwill)29,62530,11132,86433,04633,35033,43432,834
Other noncurrent assets171167180205243234214
Other undisclosed noncurrent assets15115818918995132126
Total noncurrent assets:55,96756,43459,95460,14960,18560,03459,045
TOTAL ASSETS:63,76666,22267,86967,75767,47767,19166,160
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4,0253,8893,9394,1853,8713,8423,551
Accounts payable   915   
Accrued liabilities   187   
Employee-related liabilities   571   
Taxes payable   65   
Other undisclosed accounts payable and accrued liabilities4,0253,8893,9392,4473,8713,8423,551
Debt4,2491,193 2,7892,6293,2053,050
Other liabilities2381,2261,218909961390410
Other undisclosed current liabilities  1,787    
Total current liabilities:8,5126,3076,9457,8827,4617,4377,010
Noncurrent Liabilities
Long-term debt and lease obligation, including:11,09816,72216,73416,75217,95618,35519,496
Long-term debt, excluding current maturities37404652545212,095
Capital lease obligations357339342342342344345
Other undisclosed long-term debt and lease obligation10,70416,34316,34616,35917,56017,9597,056
Liabilities, other than long-term debt6,8666,4326,7916,9469,40510,1349,922
Deferred tax liabilities, net4,5714,3674,7164,7487,6827,7887,753
Other liabilities2,2952,0652,0742,1981,7232,3462,169
Total noncurrent liabilities:17,96423,15423,52423,69927,36128,48929,418
Total liabilities:26,47629,46230,46931,58134,82235,92636,428
Stockholders' equity
Stockholders' equity attributable to parent37,29036,76037,40036,17632,65531,26529,732
Common stock82828282828281
Treasury stock, value(261)(275)(279)(283)(283)(283)(283)
Additional paid in capital25,39025,29625,15725,08225,02124,95124,851
Accumulated other comprehensive income (loss)6267281,8461,375969200(1,227)
Retained earnings11,45210,93010,5959,9216,8666,3156,310
Total stockholders' equity:37,29036,76037,40036,17632,65531,26529,732
TOTAL LIABILITIES AND EQUITY:63,76666,22267,86967,75767,47767,19166,160

Income statement (P&L) ($ in millions)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Revenues3,8723,9203,7664,1453,6983,7463,572
Revenue, net3,9203,7664,1453,6983,7463,572
Cost of revenue
(Cost of Goods and Services Sold)
(1,158)(1,108)(34)(1,264)(1,001)(1,109)(1,327)
Gross profit:2,7142,8113,7322,8812,6962,6372,245
Operating expenses(2,916)(3,089)(3,071)(3,295)(2,989)(3,347)(3,075)
Other undisclosed operating income1,1581,108341,2641,0011,1091,327
Operating income:956830694850709399497
Nonoperating expense(220)(96)(101)(149)(141)(138)(135)
Other nonoperating income (expense)(96)29231(0)35
Interest and debt expense(125)(126)(127)(154)(142)(141)(142)
Other undisclosed income from continuing operations before equity method investments, income taxes125126127154142141142
Income from continuing operations before equity method investments, income taxes:736734593701568262362
Income (loss) from equity method investments5612(3)4(1)
Income from continuing operations before income taxes:741740594704565266362
Income tax expense (benefit)(203)(124)(43)2,402(14)(24)(7)
Income from continuing operations:5376165513,106551242355
Income (loss) from discontinued operations   (1)(0)(1)20
Net income available to common stockholders, diluted:5376165513,105551240375

Comprehensive Income ($ in millions)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Net income:5376165513,105551240375
Other comprehensive income (loss)  471406 (1)271
Comprehensive income:5376161,0223,511551240646
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(101)(1,119)  7691,428 
Comprehensive income (loss), net of tax, attributable to parent:436(503)1,0223,5111,3201,668646

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: